Posted by Alex
CD occurs among all age groups but have a peak incidence in the second and third decades. CD incidence has risen over the past 20 years; CD has an incidence and prevalence rates of 5 per 100,000. The combined prevalence of the two diseases is approximately 100 per 100,000 population. CD are seen most commonly in Northern Europe and North America and in relatives of European immigrants in the cities of South Africa, Australia, and New Zealand. Inflammatory bowel disease (IBD) included Crohn’s disease and Crohn’s disease. IBD is rare in Central America, South America, Africa, the Middle East, and Asia. Although CD can be seen in all ethnic groups, there is an increased prevalence in Jews who have immigrated from Northern Europe. This Jewish predisposition is not seen in Sephardic (Mediterranean or Middle-Eastern) Jews. Although less common in the nonwhite population, more cases are being recognized in black, Hispanic, and Asian immigrants to western cities.
Read the rest of this entry »
Posted by Alex
Crohn’s disease is a recurrent segmental inflammatory disorder that may affect the any location in the gastrointestinal tract from the mouth to the anus. Crohn’s disease is of unknown etiology. Fifty percent of patients have involvement of both the small intestine and colon, whereas one third have disease limited to their small intestine and the remaining 20% have inflammation in the colon only. Perianal lesions and inflammatory conditions involving the skin, eyes, joints, and liver are common. The transmural inflammatory process and variable anatomic extent of disease contribute to diverse clinical presentations with unpredictable spontaneous exacerbations and remissions.
Posted by Alex
Huntington’s disease is a movement disorder characterized by chorea and dementia. It is inherited in an autosomal dominant manner and occurs throughout the world, in all ethnic groups, with a prevalence rate of about 5 per 100,000. The gene responsible for the disease has been located on the short arm of chromosome No. 4. At 4p16.3 there is an expanded and unstable CAG trinucleotide repeat. Symptoms do not usually develop until after 30 years of age, by which time the patient has usually had children, and so the disease continues from one generation to the next. The cause of Huntington’s disease is unknown. Online Trusted Pharmacy
Clinical Findings
Clinical onset is usually between 30 and 50 years of age. The disease is progressive and usually leads to a fatal outcome within 15–20 years. The initial symptoms may consist of either abnormal movements or intellectual changes, but ultimately both occur. The earliest mental changes are often behavioral, with irritability, moodiness, antisocial behavior, or a psychiatric disturbance, but a more obvious dementia subsequently develops. The dyskinesia may initially be no more than an apparent fidgetiness or restlessness, but eventually choreiform movements and some dystonic posturing occur. Progressive rigidity and akinesia (rather than chorea) sometimes occur in association with dementia, especially in cases with childhood onset. CT scanning usually demonstrates cerebral atrophy and atrophy of the caudate nucleus in established cases. MRI and positron emission tomography (PET) have shown reduced glucose utilization in an anatomically normal caudate nucleus. Buy Cheap Antibiotics pills
Chorea developing with no family history of choreoathetosis should not be attributed to Huntington’s disease, at least not until other causes of chorea have been excluded clinically and by appropriate laboratory studies. In younger patients, self-limiting Sydenham’s chorea develops after group A streptococcal infections on rare occasions. If a patient presents solely with progressive intellectual failure, it may not be possible to distinguish Huntington’s disease from other causes of dementia unless there is a characteristic family history or a dyskinesia develops. Canadian Prescriptions Drugs Read the rest of this entry »
Posted by Alex
Bell’s palsy is an idiopathic facial paresis of lower motor neuron type that has been attributed to an inflammatory reaction involving the facial nerve near the stylomastoid foramen or in the bony facial canal. A relationship of Bell’s palsy to reactivation of herpes simplex virus has recently been suggested, but there is little evidence to support this.
The clinical features of Bell’s palsy are characteristic. The facial paresis generally comes on abruptly, but it may worsen over the following day or so. Pain about the ear precedes or accompanies the weakness in many cases but usually lasts for only a few days. The face itself feels stiff and pulled to one side. There may be ipsilateral restriction of eye closure and difficulty with eating and fine facial movements. A disturbance of taste is common, owing to involvement of chorda tympani fibers, and hyperacusis due to involvement of fibers to the stapedius occurs occasionally. Online Canadian Pharmacy
The management of Bell’s palsy is controversial. Approximately 60% of cases recover completely without treatment, presumably because the lesion is so mild that it leads merely to conduction block. Considerable improvement occurs in most other cases, and only about 10% of all patients are seriously dissatisfied with the final outcome because of permanent disfigurement or other long-term sequelae. Treatment is unnecessary in most cases but is indicated for patients in whom an unsatisfactory outcome can be predicted. The best clinical guide to progress is the severity of the palsy during the first few days after presentation. Patients with clinically complete palsy when first seen are less likely to make a full recovery than those with an incomplete one. A poor prognosis for recovery is also associated with advanced age, hyperacusis, and severe initial pain. Electromyography and nerve excitability or conduction studies provide a guide to prognosis but not early enough to aid in the selection of patients for treatment. Buy Online Prescription Drugs
The only medical treatment that may influence the outcome is administration of corticosteroids, but studies supporting this concept have been criticized. Many physicians nevertheless routinely prescribe corticosteroids for patients with Bell’s palsy seen within 5 days of onset. The author prescribes them only when the palsy is clinically complete or there is severe pain. Treatment with prednisone, 60 or 80 mg daily in divided doses for 4 or 5 days, followed by tapering of the dose over the next 7–10 days, is a satisfactory regimen. It is helpful to protect the eye with lubricating drops (or lubricating ointment at night) and a patch if eye closure is not possible. There is no evidence that surgical procedures to decompress the facial nerve are of benefit. Men’s Health Pills
Posted by Alex
Motor neuron diseases are characterized by weakness and wasting of affected muscles, without accompanying sensory changes. Werdnig-Hoffman disease and Kugelberg-Welander syndrome occur in infants or children. Motor neuron disease in adults generally commences between 30 and 60 years of age. There is degeneration of the anterior horn cells in the spinal cord, the motor nuclei of the lower cranial nerves, and the corticospinal and corticobulbar pathways. The disorder
is usually sporadic, but familial cases may occur.
Classification
Five varieties have been distinguished on clinical grounds.
A. Progressive Bulbar Palsy: Bulbar involvement predominates owing to disease processes affecting primarily the motor nuclei of the cranial nerves.
B. Pseudobulbar Palsy: Bulbar involvement predominates in this variety also, but it is due to bilateral corticobulbar disease and thus reflects upper motor neuron dysfunction.
C. Progressive Spinal Muscular Atrophy: This is characterized primarily by a lower motor neuron deficit in the limbs due to degeneration of the anterior horn cells in the spinal cord.
D. Primary Lateral Sclerosis: There is a purely upper motor neuron deficit in the limbs.
E. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease): A mixed upper and lower motor neuron deficit is found in the limbs. This disorder is sometimes associated with dementia or parkinsonism.
Clinical Findings
A. Symptoms and Signs: Difficulty in swallowing, chewing, coughing, breathing, and talking (dysarthria) occur with bulbar involvement. In progressive bulbar palsy, there is drooping of the palate, a depressed gag reflex, pooling of saliva in the pharynx, a weak cough, and a wasted, fasciculating tongue. In pseudobulbar palsy, the tongue is contracted and spastic and cannot be moved rapidly from side to side. Limb involvement is characterized by motor disturbances
(weakness, stiffness, wasting, fasciculations) reflecting lower or upper motor neuron dysfunction; there are no objective changes on sensory examination, though there may be vague sensory complaints. The sphincters are generally spared.
The disorder is progressive and usually fatal within 3–5 years; death usually results from pulmonary infections. Patients with bulbar involvement generally have the poorest prognosis.
Read the rest of this entry »